One-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation.
Zahr F, Smith RL, Gillam LD, Chadderdon S, Makkar R, von Bardeleben RS, Ruf TF, Kipperman RM, Rassi AN, Szerlip M, Goldman S, Inglessis-Azuaje I, Yadav P, Lurz P, Davidson CJ, Mumtaz M, Gada H, Kar S, Kodali SK, Laham R, Hiesinger W, Fam NP, Keßler M, O'Neill WW, Whisenant B, Kliger C, Kapadia S, Rudolph V, Choo J, Hermiller J, Morse MA, Schofer N, Gafoor S, Latib A, Mahoney P, Kaneko T, Shah PB, Riddick JA, Muhammad KI, Boekstegers P, Price MJ, Praz F, Koulogiannis K, Marcoff L, Hausleiter J, Lim DS; CLASP IID Pivotal Trial Investigators.
Zahr F, et al. Among authors: shah pb.
JACC Cardiovasc Interv. 2023 Oct 26:S1936-8798(23)01358-4. doi: 10.1016/j.jcin.2023.10.002. Online ahead of print.
JACC Cardiovasc Interv. 2023.
PMID: 37962288